Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Non-cash Items (2024 - 2025)

Neuphoria Therapeutics (NEUP) has disclosed Non-cash Items for 2 consecutive years, with $72210.0 as the latest value for Q4 2025.

  • On a quarterly basis, Non-cash Items fell 27.79% to $72210.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $72210.0, a 27.79% decrease, with the full-year FY2025 number at $100000.0, changed N/A from a year prior.
  • Non-cash Items was $72210.0 for Q4 2025 at Neuphoria Therapeutics, up from $64902.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $79.9 million in Q3 2024 to a low of $44601.0 in Q1 2025.